EdgePoint Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

EdgePoint Investment Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09B	Buy	2,179,650 +260,653	+14%	+$125M	8.26%	4
2026 Q1	$943M	Buy	1,918,997 +533,848	+39%	+$290M	7.56%	2
2025 Q4	$803M	Sell	1,385,149 -3,513	-0.3%	-$1.99M	6.59%	5
2025 Q3	$674M	Buy	1,388,662 +65,597	+5%	+$30.5M	5.03%	10
2025 Q2	$536M	Buy	1,323,065 +977,127	+282%	+$409M	4.06%	14
2025 Q1	$172M	Buy	+345,938	New	+$187M	1.39%	22
2016 Q2	–	Sell	-686,275	Closed	-$97.2M	–	44
2016 Q1	$97.2M	Buy	686,275 +238,631	+53%	+$32M	1.68%	21
2015 Q4	$63.5M	Buy	+447,644	New	+$59.7M	1.23%	24

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

EdgePoint Investment Group's TMO Position: Q2 2026 in Review

EdgePoint Investment Group increased its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, buying an estimated $125M and bringing the position to 2,179,650 shares worth $1.09B. The position accounts for 8.26% of the portfolio, ranked #4.

EdgePoint Investment Group first reported a position in TMO in Q4 2015 and has held it in 8 quarters since. 2,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

EdgePoint Investment Group held 2,179,650 shares of Thermo Fisher Scientific worth $1.09B as of Q2 2026.
EdgePoint Investment Group bought 260,653 Thermo Fisher Scientific shares in Q2 2026, an estimated $125M.
Thermo Fisher Scientific made up 8.26% of EdgePoint Investment Group's portfolio in Q2 2026, its #4 holding.
EdgePoint Investment Group first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 8 quarters since.
2,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on EdgePoint Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.